| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ... New England Journal of Medicine 361 (17), 1651-1661, 2009 | 2265 | 2009 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1614 | 2019 |
| Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study RB Postuma, A Iranzo, M Hu, B Högl, BF Boeve, R Manni, WH Oertel, ... Brain 142 (3), 744-759, 2019 | 746 | 2019 |
| Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations RN Alcalay, OA Levy, CH Waters, S Fahn, B Ford, SH Kuo, P Mazzoni, ... Brain 138 (9), 2648-2658, 2015 | 400 | 2015 |
| Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset Z Gan-Or, N Giladi, U Rozovski, C Shifrin, S Rosner, T Gurevich, ... Neurology 70 (24), 2277-2283, 2008 | 397 | 2008 |
| Differential effects of severe vs mild GBA mutations on Parkinson disease Z Gan-Or, I Amshalom, LL Kilarski, A Bar-Shira, M Gana-Weisz, ... Neurology 84 (9), 880-887, 2015 | 347 | 2015 |
| Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R Von Coelln, ... Movement Disorders 34 (6), 866-875, 2019 | 297 | 2019 |
| Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease Z Gan-Or, PA Dion, GA Rouleau Autophagy 11 (9), 1443-1457, 2015 | 292 | 2015 |
| Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 226 | 2021 |
| Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis B Schormair, C Zhao, S Bell, E Tilch, AV Salminen, B Pütz, Y Dauvilliers, ... The Lancet Neurology 16 (11), 898-907, 2017 | 223 | 2017 |
| Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases AJ Espay, JA Vizcarra, L Marsili, AE Lang, DK Simon, A Merola, ... Neurology 92 (7), 329-337, 2019 | 214 | 2019 |
| Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ... Brain 143 (1), 234-248, 2020 | 186 | 2020 |
| The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease Z Gan-Or, LJ Ozelius, A Bar-Shira, R Saunders-Pullman, A Mirelman, ... Neurology 80 (17), 1606-1610, 2013 | 181 | 2013 |
| Gait alterations in healthy carriers of the LRRK2 G2019S mutation A Mirelman, T Gurevich, N Giladi, A Bar‐Shira, A Orr‐Urtreger, ... Annals of neurology 69 (1), 193-197, 2011 | 176 | 2011 |
| Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium K Marder, Y Wang, RN Alcalay, H Mejia-Santana, MX Tang, A Lee, ... Neurology 85 (1), 89-95, 2015 | 165 | 2015 |
| Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry AJ Lee, Y Wang, RN Alcalay, H Mejia‐Santana, R Saunders‐Pullman, ... Movement Disorders 32 (10), 1432-1438, 2017 | 158 | 2017 |
| Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder MG Miglis, CH Adler, E Antelmi, D Arnaldi, L Baldelli, BF Boeve, M Cesari, ... The Lancet Neurology 20 (8), 671-684, 2021 | 150 | 2021 |
| GBA mutations are associated with rapid eye movement sleep behavior disorder Z Gan‐Or, A Mirelman, RB Postuma, I Arnulf, A Bar‐Shira, Y Dauvilliers, ... Annals of clinical and translational neurology 2 (9), 941-945, 2015 | 145 | 2015 |
| Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations RN Alcalay, A Mirelman, R Saunders‐Pullman, MX Tang, ... Movement Disorders 28 (14), 1966-1971, 2013 | 139 | 2013 |
| Type 2 diabetes as a determinant of Parkinson's disease risk and progression H Chohan, K Senkevich, RK Patel, JP Bestwick, BM Jacobs, ... Movement disorders 36 (6), 1420-1429, 2021 | 136 | 2021 |
Guy RouleauMontreal Neurological Institute-Hospital, McGill University在 mcgill.ca 的电子邮件经过验证
